Results 231 to 240 of about 521,894 (411)
Publisher’s Note to Volumes 32 and 33
Egyptian Journal of Neurosurgery
doaj +1 more source
Ludvic Zrinzo Unit of Functional Neurosurgery, UCL Queen Square Institute of Neurology, London, UKCorrespondence: Ludvic Zrinzo, Functional Neurosurgery Unit, Department of Clinical & Motor Neurosciences, UCL Institute of Neurology, Second Floor, 33 ...
Zrinzo L
doaj
Pediatric Neurology and Neurosurgery [PDF]
Richard A. Thompson, John R. Green
openalex +1 more source
Computer- and robot-assisted Medical Intervention
Medical robotics includes assistive devices used by the physician in order to make his/her diagnostic or therapeutic practices easier and more efficient. This chapter focuses on such systems.
Troccaz, Jocelyne
core +1 more source
The Roles of Artificial Intelligence in Teaching Anatomy: A Systematic Review
ABSTRACT Anatomy education is a cornerstone of medical training and relies on cadaveric dissection and 2D illustrations. Technological advancements and integrated curricula have reduced the focus on detailed anatomy and challenged educators to engage Generation Z learners with interactive, tech‐driven methods.
Tanisha S. Joseph+8 more
wiley +1 more source
The role of advocacy and policy in advancing global neurosurgery. [PDF]
Abdul-Rahman T+12 more
europepmc +1 more source
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
Abstract Copper, one of the essential nutrients for the human body, acts as an electron relay in multiple pathways due to its redox properties. Both deficiencies and excesses of copper lead to cellular fragility. Therefore, it can manifest pro‐ and anti‐cancer properties in tumors. Therefore, it is crucial to clarify the copper activity within the cell.
Dan Shan+13 more
wiley +1 more source
K6. Studies on the Hypothermia in Neurosurgery with Special Reference to its Application
Miyoshi URABE+7 more
openalex +2 more sources
Abstract Background Glioblastoma (GBM) is largely refractory to antibodies against programmed cell death 1 (anti‐PD‐1) therapy. Fully understanding the cellular heterogeneity and immune adaptations in response to anti‐PD‐1 therapy is necessary to design more effective immunotherapies for GBM.
Rongrong Zhao+11 more
wiley +1 more source